- The stock price of Inozyme Pharma Inc (NASDAQ: INZY) increased by over 15% during intraday trading today. This is why it happened.
The stock price of Inozyme Pharma Inc (NASDAQ: INZY) – a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases of abnormal mineralization – increased by over 15% during intraday trading today. Investors are responding positively to Inozyme Pharma announcing Axel Bolte, MSc, MBA, the company’s co-founder, president, and CEO, will present at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, at 1:20 p.m. ET.
Investors appear to be expecting a major announcement from the company at the event. The presentation will be webcast live and can be accessed from the Investors & News section of Inozyme’s website under Events. And an archived replay of the webcast will be available for up to 60 days following the event.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.